Atlas Trials

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia

Clinical trial NCT05259228 · UNKNOWN

Trial details

NCT number
NCT05259228
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Tyrosine Kinase InhibitorPharmacokineticsTherapeutic Drug Monitoring
Start date
2022-12-01
Primary completion
2025-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.